TFC Financial Management’s Tango Therapeutics TNGX Stock Holding History

TFC Financial Management’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$51.6K	Buy	1,650 +100	+6%	+$2.47K	0.01%	287
2026 Q1	$32.4K	Buy	1,550 +250	+19%	+$3.48K	﹤0.01%	310
2025 Q4	$11.5K	Buy	1,300 +500	+63%	+$4.31K	﹤0.01%	388
2025 Q3	$6.72K	Buy	800 +500	+167%	+$3.38K	﹤0.01%	432
2025 Q2	$1.54K	Hold	300	–	–	﹤0.01%	533
2025 Q1	$411	Hold	300	–	–	﹤0.01%	673
2024 Q4	$927	Hold	300	–	–	﹤0.01%	580
2024 Q3	$2.31K	Buy	+300	New	+$2.86K	﹤0.01%	493

Other funds holding TNGX

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

DACS

Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

TFC Financial Management's TNGX Position: Q2 2026 in Review

TFC Financial Management increased its Tango Therapeutics (TNGX) stake by 6.5% in Q2 2026, buying an estimated $2.47K and bringing the position to 1,650 shares worth $51.6K. The position accounts for 0.01% of the portfolio, ranked #287.

TFC Financial Management first reported a position in TNGX in Q3 2024 and has held it in 8 quarters since. 24 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

TFC Financial Management held 1,650 shares of Tango Therapeutics worth $51.6K as of Q2 2026.
TFC Financial Management bought 100 Tango Therapeutics shares in Q2 2026, an estimated $2.47K.
Tango Therapeutics made up 0.01% of TFC Financial Management's portfolio in Q2 2026, its #287 holding.
TFC Financial Management first reported a position in Tango Therapeutics in Q3 2024 and has held it in 8 quarters since.
24 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.